Aberdeen Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Buy |
199,471
+26,906
| +16% | +$1.43M | 0.02% | 581 |
|
|
2025
Q1 | $7.47M | Buy |
172,565
+110,924
| +180% | +$4.8M | 0.01% | 627 |
|
|
2024
Q4 | $3.46M | Buy |
61,641
+55,104
| +843% | +$3.1M | 0.01% | 701 |
|
|
2024
Q3 | $445K | Sell |
6,537
-81,941
| -93% | -$5.58M | ﹤0.01% | 857 |
|
|
2024
Q2 | $3.74M | Sell |
88,478
-21,855
| -20% | -$923K | 0.01% | 680 |
|
|
2024
Q1 | $7.62M | Buy |
110,333
+4,227
| +4% | +$292K | 0.01% | 595 |
|
|
2023
Q4 | $7.85M | Buy |
106,106
+34,494
| +48% | +$2.55M | 0.02% | 595 |
|
|
2023
Q3 | $4.89M | Buy |
71,612
+2,992
| +4% | +$204K | 0.01% | 561 |
|
|
2023
Q2 | $6.44M | Buy |
68,620
+4,643
| +7% | +$436K | 0.02% | 538 |
|
|
2023
Q1 | $4.34M | Buy |
63,977
+15,411
| +32% | +$1.05M | 0.01% | 600 |
|
|
2022
Q4 | $2.4M | Buy |
48,566
+6,025
| +14% | +$298K | 0.01% | 682 |
|
|
2022
Q3 | $1.38M | Buy |
42,541
+19,951
| +88% | +$648K | ﹤0.01% | 749 |
|
|
2022
Q2 | $890K | Buy |
22,590
+2,005
| +10% | +$79K | ﹤0.01% | 800 |
|
|
2022
Q1 | $1.48M | Buy |
20,585
+2,651
| +15% | +$190K | ﹤0.01% | 778 |
|
|
2021
Q4 | $1.4M | Buy |
17,934
+356
| +2% | +$27.7K | ﹤0.01% | 829 |
|
|
2021
Q3 | $1.68M | Buy |
17,578
+4,189
| +31% | +$400K | ﹤0.01% | 815 |
|
|
2021
Q2 | $1.66M | Sell |
13,389
-2,465
| -16% | -$306K | ﹤0.01% | 804 |
|
|
2021
Q1 | $2.09M | Buy |
15,854
+178
| +1% | +$23.5K | ﹤0.01% | 758 |
|
|
2020
Q4 | $2.08M | Buy |
15,676
+543
| +4% | +$72K | 0.01% | 737 |
|
|
2020
Q3 | $1.54M | Sell |
15,133
-4,132
| -21% | -$421K | ﹤0.01% | 743 |
|
|
2020
Q2 | $1.68M | Buy |
19,265
+804
| +4% | +$69.9K | ﹤0.01% | 724 |
|
|
2020
Q1 | $1.07M | Buy |
18,461
+353
| +2% | +$20.5K | ﹤0.01% | 757 |
|
|
2019
Q4 | $1.67M | Buy |
18,108
+1,086
| +6% | +$100K | ﹤0.01% | 744 |
|
|
2019
Q3 | $1.54M | Buy |
17,022
+9,800
| +136% | +$886K | ﹤0.01% | 748 |
|
|
2019
Q2 | $852K | Buy |
+7,222
| New | +$852K | ﹤0.01% | 837 |
|